Moderna integrates AI into skin cancer therapeutic development

Moderna is utilizing artificial intelligence to advance its skin cancer treatment pipeline, marking a shift in pharmaceutical R&D methodology. While the specific technical role of the AI remains opaque, the integration suggests a broader trend of leveraging machine learning to accelerate clinical outcomes in oncology.